We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn about our cookie policy.
Sigma-Aldrich Age Inhibitor Lr-90
List Price $252.88 Your Price $252.88
Sigma-Aldrich Age Inhibitor Lr-90 - SIAL (Additional S&H Or Hazmat Fees May Apply)
NETA PART: SIAL-5307990001
MFG.PART: 5307990001
UNSPSC: 12352200
Manufacturer: Sigma-Aldrich


Assay
≥97% (HPLC)
Quality Level
100
Form
powder
Manufacturer/Tradename
Calbiochem®
Storage Condition
OK to freeze
protect from light
Color
off-white
Solubility
DMSO: 100 mg/mL
Storage Temp.
2-8°C
General Description
A cell-permeable methylene bisphenylureido derived compound that blocks the formation of advanced glycation endproduct (AGE) by scavenging dicarbonyl intermediates and by chelating transition metals that catalyze the production of AGE. Inhibits metal ion-catalyzed oxidation of ascorbate (IC50= 275 µM). Exhibits protective effects against diabetic nephropathy, retinopathy, and atherosclerosis and reduces arterial stiffness in diabetic animals (~50 mg/L drinking water) by reducing collagen accumulation and cross-linking. Although it does not affect glycemic condition and body weight in normal and diabetic animals, it reduces plasma triglycerides and glycated hemoglobin levels in diabetic rats and improves their cardiac output and stroke volume. Also shown to suppress S100b and TNFa-induced activation of NF-κB.Please note that the molecular weight for this compound is batch-specific due to variable water content.A cell-permeable methylene bisphenylureido derived compound that blocks the formation of advanced glycation endproduct (AGE) by scavenging dicarbonyl intermediates and by chelating transition metals that catalyze the production of AGE. Inhibits metal ion-catalyzed oxidation of ascorbate (IC50= 275 µM). Exhibits protective effects against diabetic nephropathy, retinopathy, and atherosclerosis and reduces arterial stiffness in diabetic animals (~50 mg/L drinking water) by reducing collagen accumulation and cross-linking. Although it does not affect glycemic condition and body weight in normal and diabetic animals, it reduces plasma triglycerides and glycated hemoglobin levels in diabetic rats and improves their cardiac output and stroke volume. Also shown to suppress S100b and TNFa-induced activation of NF-kB.
Biochem/Physiol Actions
Cell permeable: yesPrimary Target=IF(SGM_MetricTransfer!C11=,,SGM_MetricTransfer!C11)
Packaging
Packaged under inert gasWarning
Toxicity: Standard Handling (A)Reconstitution
Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.Other Notes
Satheesan, S., et Al. 2014.Br. J. Pharmacol. 171,3103.Nagai, R., et Al. 2012.Diabetes. 61,549.
Figarola, J.L., et Al. 2008.Diabetologia. 51,882.
Figarola, J.L., et Al. 2003.Diabetologia. 46,1140.CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
| SKU | SIAL-5307990001 |
|---|---|
| Supplier Part Number | 5307990001 |
| UM | EA |
| UNSPSC | 12352200 |
| Manufacturer | Sigma-Aldrich |
| ProductLine | SIAL |
| Qty | 1 |
| MinOrderQty | 1 |
| Weight | 10.000000 |
| Lead Time | 9 |
| Hazardous | N |
| Energy Star | No |
| Green | No |
| Controlled | N |

